Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Conditions
Bipolar 1 Disorder
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Pillar Clinical Research - Little Rock, Little Rock, Arkansas, United States
Contact: Study coordinator (Leslie Smith, MD)Contact: Principal Investigator (Leslie Smith, MD)Woodland International Research Group, Little Rock, Arkansas, United States
Woodland Research Northwest, Rogers, Arkansas, United States
Contact: Study coordinator (Robert Billingsley, MD)Contact: Principal Investigator (Robert Billingsley, MD)Inland Psychiatric Medical Group - Chino, Chino, California, United States
Synergy Clinical Research Center - San Diego, Lemon Grove, California, United States
Contact: Study coordinator (Charmaine Semeniuk, MD)Contact: Principal Investigator (Charmaine Semeniuk)Collaborative Neuroscience Research - Los Alamitos, Los Alamitos, California, United States
Contact: Study coordinator (David P Walling, PhD)Contact: Principal Investigator (David P Walling, PhD)NRC Research Institute - Orange, Orange, California, United States
Contact: Study coordinator (Daniel Chueh, MD)Contact: Principal Investigator (Daniel Chueh, MD)CNRI - San Diego, LLC, San Diego, California, United States
NeuroBehavioral Hospitals of the Palm Beaches - South, Boynton Beach, Florida, United States
Contact: Study coordinator (Mohammad Asim Nisar, MD)Contact: Principal Investigator (Mohammad Asim Nisar, MD)United Research Institute, Hialeah, Florida, United States
Contact: Study coordinator (Patrick Pinchinat, MD)Contact: Principal Investigator (Patrick Pinchinat)CenExel - Hollywood, Hollywood, Florida, United States
Contact: Study coordinator (Edwin Gomez, MD)Contact: Principal Investigator (Edwin Gomez, MD)Segal Trials - Miami Lakes Medical Research Early Phase, Inpatient & Outpatient Site, Miami Lakes, Florida, United States
Contact: Study coordinator (Rishi Kakar, MD)Contact: Principal Investigator (Rishi Kakar, MD)Neuroscience Research Institute at Ambrosia, West Palm Beach, Florida, United States
Contact: Study coordinator (Danesh Alam, MD)Contact: Principal Investigator (Danesh Alam, MD)CenExel - Decatur, Decatur, Georgia, United States
Contact: Study coordinator (Kimball Johnson, MD)Contact: Principal Investigator (Kimball Johnson, MD)Pillar Clinical Research - Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Roueen Rafeyan, MD)Contact: Principal Investigator (Roueen Rafeyan, MD)CenExel - Gaithersburg, Gaithersburg, Maryland, United States
Arch Clinical Trials, St Louis, Missouri, United States
Contact: Study coordinator (Kulsoom Juniad, MD)Contact: Principal Investigator (Kulsoom Juniad, MD)Richmond Behavioral Associates, Staten Island, New York, United States
Contact: Study coordinator (Peter Weiden)Contact: Principal Investigator (Peter Weiden, MD)New Hope Clinical Research, Charlotte, North Carolina, United States
Contact: Study coordinator (Kurian Abraham, MD)Contact: Principal Investigator (Kurian Abraham)Community Clinical Research, Inc., Austin, Texas, United States
Contact: Study coordinator (Samuel Collier, MD)Contact: Principal Investigator (Samuel Collier, MD)HD Research - Memorial Hermann Village, Houston, Texas, United States
Pillar Clinical Research - Richardson, Richardson, Texas, United States
Study leads
Edwin A Gomez, MD
Principal Investigator
CenExel Research Centers of America